مجموعة اللوائح العالمية
تصفح 15,074 لائحة من 36 جهة تنظيمية
2,983 تم تحديثها في آخر 30 يومًا. مجموعة عامة — لا حاجة إلى تسجيل للقراءة.
عرض 151–200 من أصل 222 لائحة
Technical Regulation for Automated Motorcycles
Saudi Arabia's technical regulation establishes standards for automated motorcycles, covering design, performance, safety and operational requirements for motorcycles with automated or semi-automated control systems.
Technical Regulation for equipment safety: part 1
Saudi Arabian technical regulation establishing safety requirements for equipment. This standard addresses equipment design, manufacturing, and performance criteria to protect workers and ensure safe operation across industrial and commercial applications.
Technical Regulation for Child restraint systems and strollers
Saudi Arabian technical regulation establishing safety and performance standards for child restraint systems and strollers. Specifies design, construction, testing, and labeling requirements to protect children during transport and use.
Technical Regulation for Solar Photovoltaic Systems
Saudi Arabian Standards Organization technical regulation establishing requirements and specifications for solar photovoltaic systems, covering design, manufacture, installation, testing, and performance standards to ensure safety, quality, and efficiency of PV systems in the Kingdom.
Technical Regulation for Glue and Adhesive Materials
Saudi Arabian Standards Organization technical regulation establishing requirements and specifications for glue and adhesive materials, covering composition, performance, safety, and labeling standards for industrial and consumer applications.
Technical Regulation of Textile Products: Issue 2
Saudi Arabian technical regulation establishing standards for textile products. Issue 2 sets out requirements for textile material properties, safety, labeling, and quality specifications applicable to textile manufacturers and importers.
Technical Regulation for doors, windows, and accessories
Saudi Arabia's technical regulation establishes standards for doors, windows, and their accessories, covering design, materials, performance, testing, and safety requirements for these building components.
Technical Regulation for Electrical Batteries
Saudi Arabia's technical regulation establishes standards for electrical batteries, covering design, manufacturing, safety, performance, and labeling requirements to ensure product quality, consumer safety, and environmental protection in battery production and commerce.
Technical regulation of Amusement parks games and devices
Saudi Arabian technical regulation establishing safety and operational standards for amusement park games and devices. The regulation sets requirements for design, construction, installation, maintenance, and operation of amusement park equipment to protect public safety and worker welfare.
Technical Regulation for Footwear and their Accessories
Saudi Arabian technical regulation establishing standards for footwear and their accessories, covering design, materials, construction, safety, and performance requirements to ensure product quality and consumer protection.
Technical Regulation for Toys adopted from GCC Technical Regulation on Children Toys: Iss... Download
Saudi Arabia adopts a technical regulation for toys aligned with GCC Technical Regulation on Children Toys. The standard establishes safety and quality requirements for toy manufacturing and importation to protect children from hazards.
The General Regulations for the Saudi Quality Mark
Saudi Arabia's general regulations establish requirements and procedures for the Saudi Quality Mark certification scheme, which verifies that products and services meet specified quality standards set by the Saudi Standards, Metrology and Quality Organization (SASO).
Technical Regulation for Ornaments and Accessories
Saudi Arabia's technical regulation establishes standards for ornaments and accessories, covering product specifications, safety requirements, and quality criteria applicable to manufacturers and importers in this sector.
Technical Regulations for Limiting Hazardous Substances in Electrical and Electronic Devic...
Saudi Arabia's technical regulations establish limits on hazardous substances in electrical and electronic devices, aligning with international standards to restrict materials like lead, mercury, cadmium, and brominated flame retardants in manufacturing and product safety.
Technical Regulation for Low Voltage Electrical Equipment and Appliances Download
Saudi Arabia's technical regulation establishes safety and performance requirements for low-voltage electrical equipment and appliances, covering design, manufacture, testing, and labeling standards to ensure consumer safety and product reliability in the domestic market.
Technical Regulation for Electrical Self-Balancing Boards (Scooter)
Saudi Arabia's technical regulation establishes safety and performance standards for electrical self-balancing boards (scooters), covering design, manufacturing, testing, and operational requirements to ensure consumer safety and product quality.
Technical Regulation for Auto Spare Parts
Saudi Arabia's SASO technical regulation establishes standards for automotive spare parts, covering quality, safety, and performance requirements for components used in vehicle manufacture and repair.
Importation of Electronic Products
CFR Part 1005 establishes importation requirements for electronic products subject to federal radiation control standards. Imported electronic products must bear compliance certification labels or tags; non-complying products are refused entry unless brought into compliance through a petition process. The regulation provides procedures for sample testing, inspection, notification, and hearing rights for importers.
Labeling
FDA regulation 21 CFR Part 801 establishes labeling requirements for medical devices in package form. Manufacturers, packers, and distributors must conspicuously display their name and place of business (including street address, city, state, and ZIP code) on device labels. Labels must clarify the relationship between the labeled entity and the device (e.g., "Manufactured for", "Distributed by"). The regulation defines key terms including implantable devices, finished devices, expiration dates, and automatic identification and data capture (AIDC) technology for unique device identification.
Labeling and Packaging Requirements for Controlled Substances
21 CFR Part 1302 establishes labeling and packaging requirements for controlled substances distributed in the United States. Manufacturers must print schedule symbols on commercial containers and labeling in a prominent, easily identifiable manner. Specific exemptions apply to containers too small to accommodate labels, clinical research involving blind studies, and exported substances. All containers must be sealed to detect tampering. These requirements apply to imported controlled substances but not to those intended for export.
Quality Management System Regulation
21 CFR Part 820 establishes Current Good Manufacturing Practice (CGMP) requirements for the design, manufacture, packaging, labeling, storage, installation, and servicing of finished medical devices intended for human use. Manufacturers must establish and maintain a quality management system appropriate for their specific devices. The regulation applies to devices manufactured in the US or imported into the US, and covers manufacturers performing functions such as contract sterilization, relabeling, remanufacturing, and repacking. Blood components and certain other exempted products are excluded.
Additional Standards for Miscellaneous Products
21 CFR Part 680 establishes standards for allergenic products used in diagnosis, prevention, or treatment of allergies. Requirements cover source material purity (max 1% foreign material), mold culture processing with approved standard operating procedures, and animal sourcing with veterinary oversight. Manufacturers must document mold identity, processing steps, contamination limits, and report specified animal diseases to the Center for Biologics Evaluation and Research.
Exemptions from Federal Preemption of State and Local Medical Device Requirements
21 CFR Part 808 establishes procedures for states and localities to seek exemption from federal preemption of medical device requirements under the Federal Food, Drug, and Cosmetic Act. The FDA Commissioner may grant exemptions for state/local requirements that are either more stringent than federal standards or required by compelling local conditions, provided they do not conflict with federal law. General applicability requirements and those identical to federal standards remain non-preempted.
Clinical Chemistry and Clinical Toxicology Devices
21 CFR Part 862 establishes the FDA classification framework for clinical chemistry and clinical toxicology devices intended for human use. It defines the scope of device regulation, specifies that calibrators used with these devices are classified as Class II regardless of the device's classification due to their critical role in measurement accuracy, and outlines the premarket approval requirements and effective dates for devices classified as Class III.
General
21 CFR Part 800 establishes sterility and tamper-resistant packaging requirements for contact lens solutions and ophthalmic medical devices. All contact lens solutions, eye cups, and similar ophthalmic preparations must be sterile at the time of filling and closing, with appropriate labeling and warnings. Multiple-dose containers must contain preservatives or be labeled with duration limits. Products failing to meet these standards are considered adulterated or misbranded.
Food Additives Permitted in Feed and Drinking Water of Animals
21 CFR Part 573 establishes permitted food additives for animal feed and drinking water. Regulations cover acrylamide-acrylic acid resin as a thickener/suspending agent in aqueous feed suspensions, aminoglycoside 3'-phosphotransferase II enzyme for genetic modification of crops, ammoniated cottonseed meal as a protein source in ruminant feed (max 20% of ration), and ammoniated rice hulls as fiber and nonprotein nitrogen source in beef cattle feed (max 20% of ration). Each additive includes specifications, approved uses, and labeling requirements for safe application.
Performance Standards for Electronic Products: General
Performance standards for electronic products under 21 CFR Part 1010 establish certification and labeling requirements to control electronic product radiation. Manufacturers must certify conformance to applicable standards via permanently affixed labels or tags, with certification based on individual product testing or qualified manufacturing programs. The regulation covers general provisions for radiation control and includes specific provisions for laser products incorporating certified laser systems.
Performance Standards for Light-Emitting Products
FDA performance standards for laser products manufactured after August 1, 1976, establishing safety classifications (Class I, IIa, II, etc.) and accessible emission limits to protect human exposure to laser radiation. Manufacturers must register products, provide warning labels and safe installation instructions, and maintain distribution records.
Additional Standards for Diagnostic Substances for Laboratory Tests
21 CFR Part 660 establishes additional standards for diagnostic substances used in laboratory tests, specifically covering antibody to hepatitis B surface antigen. The regulation defines proper sourcing from immunized animal plasma/blood or hepatitis B surface antigen-positive human donors, specifies processing methods to ensure specificity and potency, and mandates labeling requirements including source indication, test method recommendations, and hepatitis transmission warnings. Ancillary reagents must meet purity standards and be manufactured to prevent contamination.
Oral Dosage Form New Animal Drugs
21 CFR Part 520 establishes specifications and conditions of use for oral dosage form new animal drugs, including acepromazine (tranquilizer for dogs and cats), acetazolamide (for heart failure and intraocular pressure in dogs), afoxolaner/moxidectin/pyrantel combination (for heartworm prevention and parasite control in dogs), and albendazole suspension (for livestock). All drugs require veterinary oversight and specify dosage amounts, indications for use, and applicable limitations.
General Biological Products Standards
21 CFR Part 610 establishes general standards for licensed biological products in the US, requiring manufacturers to complete conformity tests on each product lot before release and permitting FDA oversight of lot samples and protocols. The regulation specifies testing requirements for potency, sterility, and safety, allows equivalent methods with FDA approval, and governs release procedures through the Center for Biologics Evaluation and Research or Center for Drug Evaluation and Research.
Medical Device Classification Procedures
21 CFR Part 860 establishes the procedures and criteria for classifying and reclassifying medical devices intended for human use into one of three regulatory control classes (I, II, or III) based on safety and effectiveness. The regulation defines classification criteria, describes the roles of advisory committees and the FDA Commissioner, and prescribes the data required to support device classification determinations. It also governs public participation and information disclosure in classification proceedings.
Regulations Under the Federal Caustic Poison Act
21 CFR Part 1230 establishes labeling and packaging requirements for caustic and corrosive substances shipped in interstate or foreign commerce. Containers must bear clear labels with the common name of the dangerous substance, prominent "Poison" warnings in 24-point Gothic capitals, and directions for medical treatment in case of internal or external injury. Labeling must be firmly affixed and readily visible. Manufacturers, wholesalers, and distributors are responsible for compliance, with limited exemptions for non-household containers at shipment.
Repurchase, Repairs, or Replacement of Electronic Products
CFR Part 1004 establishes manufacturer obligations for electronic products that fail to comply with federal standards or have defects. Manufacturers must repair and bring products into conformity, replace them with equivalent compliant products, or refund the purchase price at no cost to consumers, including reimbursement for transportation. Manufacturers must submit detailed plans to the Secretary for approval before executing repairs or replacements.
Unique Device Identification
21 CFR Part 830 establishes requirements for unique device identification (UDI) of medical devices. The regulation defines key terms including UDI, device identifier, production identifier, labeler, and automatic identification and data capture (AIDC) technology. UDIs must adequately identify devices through distribution and use, comprising a fixed device identifier and conditional production identifier elements such as lot/batch number, serial number, expiration date, or manufacturing date. The Global Unique Device Identification Database (GUDID) serves as the repository for device identification information.
Food Additives
21 CFR Part 570 establishes regulatory definitions and provisions governing food additives under the Federal Food, Drug, and Cosmetic Act. It defines food additives as substances not exempted that become food components or affect food characteristics, including packaging materials with migration potential. The regulation outlines safety standards, requiring reasonable certainty of harmlessness based on scientific procedures, and addresses general recognition of safety, cumulative dietary effects, and prior sanctions.
Cosmetic Labeling
21 CFR Part 701 establishes labeling requirements for cosmetic products, including prohibitions on misbranding, specifications for ingredient declaration in descending order of predominance, and standards for label prominence and conspicuousness. Requirements address language, visibility, and accurate ingredient representation to prevent consumer deception.
Current Good Manufacturing Practice for Blood and Blood Components
21 CFR Part 606 establishes current good manufacturing practice (cGMP) standards for blood and blood components collection, processing, compatibility testing, storage and distribution. The regulation defines key terms including blood, blood components, plasmapheresis, plateletpheresis, and leukapheresis procedures. It requires facilities and personnel to maintain adequate safety, purity, potency and effectiveness, with personnel having appropriate education, training and experience. Facilities must be clean, orderly, suitably constructed and properly maintained to ensure compliance with cGMP requirements.
Performance Standards for Ionizing Radiation Emitting Products
21 CFR Part 1020 establishes performance standards for ionizing radiation emitted by television receivers with cathode ray tubes manufactured after January 15, 1970. The regulation limits radiation exposure rates to 0.5 milliroentgens per hour at 5 centimeters from the external surface, with measurement requirements and testing conditions specified for user controls, service controls, and component failure scenarios. Manufacturers must affix warning labels on receivers exceeding exposure limits.
Requirements for Electronic Orders and Prescriptions
21 CFR Part 1311 establishes requirements for electronic orders and prescriptions of controlled substances, particularly Schedule I and II drugs. It mandates that electronic transmission systems meet authentication, nonrepudiation, and message integrity standards, with digital signatures using Public Key Infrastructure (PKI) technology identified as compliant. The regulation incorporates by reference cryptographic security standards from NIST, including FIPS publications 140-2, 180-2, and 180-3.
Notification of Defects or Failure to Comply
21 CFR Part 1003 establishes notification requirements for manufacturers of electronic products regarding defects or non-compliance with Federal standards, particularly those involving unintended or excessive electronic product radiation emissions that pose injury risk. Manufacturers must immediately notify the Secretary and relevant dealers, distributors, and purchasers upon discovery of defects or compliance failures in products manufactured after October 1968.
Irradiation in the Production, Processing, and Handling of Animal Feed and Pet Food
21 CFR Part 579 establishes safety standards for using ionizing radiation in animal feed and pet food production. Facilities may use gamma rays (cobalt-60, cesium-137) or electrons (up to 10 MeV) to treat complete animal diets and ingredients. For poultry feed, additional X-ray sources are permitted. Minimum effective dose for salmonella control is 2.0 kGy; maximum is 25 kGy. Facilities must comply with Part 507 and incorporate applicable Part 179 food irradiation regulations.
Procedures for Performance Standards Development
21 CFR Part 861 establishes procedures for FDA development of performance standards for Class II and Class III medical devices. Standards address device performance characteristics, design, manufacturing processes, quality control, testing requirements, labeling, and distribution restrictions to ensure safety and effectiveness. The FDA coordinates with other federal agencies and stakeholder organizations in standard-setting.
Food Substances Affirmed as Generally Recognized as Safe in Feed and Drinking Water of Animals
This regulation affirms certain food substances as generally recognized as safe (GRAS) for use in animal feed and drinking water. Specific substances listed include ethyl alcohol with ethyl acetate as an energy source in ruminant supplements, hydrophobic silicas as anticaking agents in vitamin preparations (limited to 5%), and 25-hydroxyvitamin D3 as a vitamin D3 source in broiler chicken feed and water (not exceeding 69 ppb in feed or 34.5 ppb in water), each with defined purity and usage specifications.
Human Cells, Tissues, and Cellular and Tissue-Based Products
21 CFR Part 1271 establishes FDA requirements for establishments manufacturing human cells, tissues, and cellular and tissue-based products (HCT/Ps). The regulation creates an electronic registration and listing system and mandates compliance with donor-eligibility procedures, current good tissue practice standards, and communicable disease prevention measures. It applies to HCT/P manufacturers regulated under the Public Health Service Act, whether or not products enter interstate commerce, and requires adherence to manufacturing and quality standards.
New Animal Drugs for Minor Use and Minor Species
This regulation (21 CFR Part 516) establishes procedures for designating and approving new animal drugs for minor uses and minor species, implementing section 573 of the Federal Food, Drug, and Cosmetic Act. It defines key terms including minor use, minor species, major species, MUMS drugs, and requirements for demonstrating functional superiority. The rule governs various dosage forms including oral, injectable, ophthalmic, topical, and feed-based formulations for animals other than humans or major livestock species.
Additional Standards for Human Blood and Blood Products
21 CFR Part 640 establishes manufacturing and quality standards for human whole blood and blood products intended for transfusion. Requirements cover donor examination, blood collection using sterile pyrogen-free containers with approved anticoagulants, storage at 1–6 °C, labeling, tamper-proof sealing, and aseptic processing to prevent contamination. Licensed establishments must supervise all manufacturing steps including donor identification, laboratory testing, and reissue conditions.
General
21 CFR Part 1000 establishes general provisions and definitions for the regulation of electronic products that emit radiation under the Federal Food, Drug, and Cosmetic Act. Key terms include electronic product radiation (ionizing or nonionizing electromagnetic or particulate radiation, or sonic/ultrasonic waves), electronic products (manufactured items containing electronic circuits that emit such radiation), and related industry roles such as manufacturers, distributors, and dealers. The regulation provides foundational definitions for chassis families, component classifications, and model designations used in subsequent radiation safety standards.
Cosmetic Product Warning Statements
21 CFR Part 740 establishes requirements for warning statements on cosmetic product labels. Manufacturers must display warnings whenever necessary to prevent health hazards, with statements appearing prominently in bold type on contrasting backgrounds (minimum 1/16 inch height). Specific warnings are mandated for products with unsubstantiated safety claims and for self-pressurized containers, including precautions against eye contact, puncture, incineration, and high temperature exposure.
Performance Standard for Electrode Lead Wires and Patient Cables
This regulation establishes a performance standard for electrode lead wires and patient cables used with medical devices, requiring connectors with conductive patient connections to comply with IEC 601-1 subclause 56.3(c). Manufacturers must demonstrate compliance through inspection and testing by May 1998 for specified devices and May 2000 for others, with provisions for exemptions or variances upon petition.